Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Avanir Pharmaceuticals Inc

AVNR:US

Acquired

Company Profile for Avanir Pharmaceuticals Inc (AVNR)

Avanir Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases. The Company develops treatments for pseudobulbar affect, diabetic peripheral neuropathic pain, and other conditions. AVANIR out-licensed its moniclonal antibodies, and produces an over-the-counter treatment for cold sores.

Contact Information

Avanir Pharmaceuticals Inc

101 Enterprise
Suite 300
Aliso Viejo, CA 92656
United States
Phone: 1-949-389-6700

Key Executives for Avanir Pharmaceuticals Inc (AVNR)

Keith A KatkinPresident/CEORohan PalekarSenior VP/Chief Commercial Ofcr
Gregory J Flesher "Greg"Senior VP:Corporate Dev/Chief Bus OfcrJoao SiffertSenior VP:R&D/Chief Scientific Ofcr
Christine G OcampoVP:Finance/Chief Acctg Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil